Lista de obras - Mattia Boeri - Dominio Público Uruguay

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

scientific article published on 11 September 2018

Assessment of circulating microRNAs in plasma of lung cancer patients.

artículo científico publicado en 2014

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

artículo científico publicado en 2018

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy

scientific article published on 03 January 2019

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer

artículo científico publicado en 2017

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

artículo científico publicado en 2018

Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know

artículo científico publicado en 2014

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study

artículo científico publicado en 2019

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

artículo científico publicado en 2015

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

artículo científico publicado en 2019

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

artículo científico publicado en 2014

DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]

artículo científico publicado en 2014

Development of a molecular blood-based immune signature classifier as biomarker for risks assessment in Lung Cancer screening

artículo científico publicado en 2022

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

artículo científico publicado en 2017

Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer

scientific article published on 25 June 2019

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations

artículo científico publicado en 2015

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis

artículo científico publicado en 2020

Inflammatory status and lung function predict mortality in lung cancer screening participants

artículo científico publicado en 2018

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

artículo científico publicado en 2017

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature

artículo científico publicado en 2016

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

artículo científico publicado en 2011

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction

artículo científico publicado en 2014

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

artículo científico publicado en 2017

Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial

scientific article published on 03 April 2019

Potential biomarkers for lung cancer screening

artículo científico publicado en 2014

Prognostic determinants in epithelioid sarcoma.

artículo científico publicado en 2011

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

scientific article published on 01 July 2019

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging

artículo científico

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis

artículo científico

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants

artículo científico publicado en 2016

Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening

scientific article published on 20 July 2019

Therapeutic use of microRNAs in lung cancer

artículo científico publicado en 2014

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

artículo científico publicado en 2020

Lista de obras de Mattia Boeri

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Assessment of circulating microRNAs in plasma of lung cancer patients.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected]

Development of a molecular blood-based immune signature classifier as biomarker for risks assessment in Lung Cancer screening

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis

Inflammatory status and lung function predict mortality in lung cancer screening participants

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial

Potential biomarkers for lung cancer screening

Prognostic determinants in epithelioid sarcoma.

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants

Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening

Therapeutic use of microRNAs in lung cancer

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy